PMC:7105881 / 57336-57601 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T328","span":{"begin":36,"end":40},"obj":"Body_part"},{"id":"T329","span":{"begin":201,"end":208},"obj":"Body_part"}],"attributes":[{"id":"A328","pred":"fma_id","subj":"T328","obj":"http://purl.org/sig/ont/fma/fma24728"},{"id":"A329","pred":"fma_id","subj":"T329","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"However, these subunit vaccines may face some important challenges, mostly arising from their relatively low immunogenicity, which must be combined with appropriate adjuvants or optimized for suitable protein sequences, fragment lengths, and immunization schedules."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T19","span":{"begin":36,"end":40},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"uberon_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/UBERON_0001456"}],"text":"However, these subunit vaccines may face some important challenges, mostly arising from their relatively low immunogenicity, which must be combined with appropriate adjuvants or optimized for suitable protein sequences, fragment lengths, and immunization schedules."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T663","span":{"begin":36,"end":40},"obj":"http://purl.obolibrary.org/obo/UBERON_0001456"}],"text":"However, these subunit vaccines may face some important challenges, mostly arising from their relatively low immunogenicity, which must be combined with appropriate adjuvants or optimized for suitable protein sequences, fragment lengths, and immunization schedules."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7910","span":{"begin":165,"end":174},"obj":"Chemical"},{"id":"T93211","span":{"begin":201,"end":208},"obj":"Chemical"}],"attributes":[{"id":"A8840","pred":"chebi_id","subj":"T7910","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A36357","pred":"chebi_id","subj":"T93211","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"However, these subunit vaccines may face some important challenges, mostly arising from their relatively low immunogenicity, which must be combined with appropriate adjuvants or optimized for suitable protein sequences, fragment lengths, and immunization schedules."}

{"project":"LitCovid-sentences","denotations":[{"id":"T306","span":{"begin":0,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, these subunit vaccines may face some important challenges, mostly arising from their relatively low immunogenicity, which must be combined with appropriate adjuvants or optimized for suitable protein sequences, fragment lengths, and immunization schedules."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T956","span":{"begin":109,"end":123},"obj":"BV_15"},{"id":"T957","span":{"begin":165,"end":174},"obj":"CHEBI:60809;CHEBI:60809"},{"id":"T9588","span":{"begin":109,"end":123},"obj":"BV_15"},{"id":"T18188","span":{"begin":165,"end":174},"obj":"CHEBI:60809;CHEBI:60809"}],"text":"However, these subunit vaccines may face some important challenges, mostly arising from their relatively low immunogenicity, which must be combined with appropriate adjuvants or optimized for suitable protein sequences, fragment lengths, and immunization schedules."}